Ongoing Clinical Trials

Clinical Trials Currently Recruiting Patients:

Dermatology Research Registry 

If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online at: https://unc.az1.qualtrics.com/jfe/form/SV_e2oTA4coH0gGvuR

Your information will be kept confidential and will only be used to contact you about potential research studies.  Your information will not be shared.

 

Atopic Dermatitis (Eczema) Research Study (Oral Medication)


Requirements: Adult patients (18+) with moderate to severe atopic dermatitis.  Additional treatments other than the study medication are not permitted during the study period.  
Duration: 7 total visits, 2 week screening period, 8 week treatment period, plus a follow-up visit 2 weeks after completing therapy.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

 

Sponsor: Supported by DS Biopharma

 

For more information please contact:    Lauren Brown
                                                                    984-974-3682
                                                                    brownln@email.unc.edu

 

Seeking Patients with Moderate to Severe Plaque Psoriasis for a 1 year comparison study of two approved injectable medications for the treatment of psoriasis.

 

Requirements: Subjects must be 18 years or older with moderate-severe plaque psoriasis. Be in general good health and willing to stop other psoriasis treatments.

Duration: 52 Weeks of treatment. There will be up to 18 study visits over a 52-56 week period at UNC Dermatology.

Details: Subject compensation available. Study medication and study-related exams will be provided at no cost.

For more information, please contact:


Laura Keck

Study Coordinator

UNC Dermatology and Skin Cancer Center

984-974-3682

lmcleod@email.unc.edu

 

Pediatric Psoriasis Research Study (Topical Medication)


Requirements: Pediatric patients (2-11 years) with mild to moderate plaque type psoriasis affecting the body and scalp.  Additional treatments other than the study medication are not permitted during the study period.  
Duration: 4 total visits, 2 week screening period, 8 week treatment period, plus a follow-up phone call one week after the last study visit.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

 

Sponsor: Supported by Stiefel, a GSK company

 

For more information please contact:    Lauren Brown
                                                                    984-974-3682
                                                                    
brownln@email.unc.edu

 

 

 

Your Physician:
Aida Lugo-Somolinos, MD
Link to Dr. Lugo-Somolinos' Research